Dapagliflozin Tablets 10 mg is a high-quality pharmaceutical formulation specifically designed for the effective management of diabetes mellitus. Manufactured under stringent WHO-GMP compliant conditions by IndiGlobal Exports, this tablet ensures precision in dosage and consistent therapeutic efficacy. Each 10 mg tablet contains a clinically validated amount of dapagliflozin, an SGLT2 inhibitor that aids in reducing blood glucose levels by promoting renal glucose excretion. The product is packaged in export-grade blister or strip packs, ensuring product integrity and suitability for international markets. It guarantees reliable performance in both hospital and retail pharmacy environments, compliant with international pharmacopoeial standards (IP/USP). Ideal for bulk institutional supply or export purposes, this dapagliflozin formulation supports ongoing diabetes care with proven safety and efficacy.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Dapagliflozin 10 mg |
| Intended Use | Management of diabetes mellitus |
| Dosage Form | Tablet |
| Packaging | Export-grade blister or strip packs |
| Manufacturing Standards | WHO-GMP compliant facility |
| Pharmacopoeial Compliance | IP/USP standard |
| Therapeutic Class | SGLT2 inhibitor |
| Manufacturer | IndiGlobal Exports |
| Suitable Markets | International pharmaceutical and export markets |
| Shelf Life | As per regulatory standards |
| Attributes | Description |
|---|---|
| Category | Diabetes |
| Formulation | Tablet |
| Strength | 10 mg per tablet |
| Packaging Type | Blister or strip packs suitable for export |
| Storage Conditions | Store in a cool, dry place away from direct sunlight |
| Dosage Recommendation | As prescribed by healthcare professionals |
| Quality Certifications | Manufactured under WHO-GMP; Complies with IP/USP pharmacopoeial standards |
| Intended Market | Export and regulated pharmaceutical sectors |
| Manufacturer | IndiGlobal Exports |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Dapagliflozin Tablets 10 mg are manufactured in WHO-GMP compliant facilities and adhere to Indian Pharmacopoeia (IP) and United States Pharmacopeia (USP) quality standards, ensuring high therapeutic and safety benchmarks.
The tablets are available in export-grade blister or strip packs designed to maintain product stability and comply with international shipping and storage requirements.
Yes, the product complies with global regulatory standards, making it appropriate for both regulated and semi-regulated markets worldwide.
Dapagliflozin acts as an SGLT2 inhibitor, lowering blood glucose levels by promoting renal excretion of glucose, thus assisting in effective glycemic control.
Yes, the product packaging and manufacturing scale support bulk orders suitable for hospital and retail pharmacy supply chains.
Brand: indiglobal exports
Country Of Origin: India
Dapagliflozin Tablets 10 mg is a pharmaceutical product indicated for diabetes treatment. This formulation is manufactured with export-quality standards to ensure therapeutic efficacy, consistent dosage, and compliance with international healthcare regulations.
Features:Dapagliflozin Tablets 10 mg is developed for the effective management of diabetes conditions, offering reliable performance backed by stringent pharmaceutical standards. Each batch is carefully produced and tested to ensure consistency, safety, and compliance with global export norms.
This formulation supports the clinical treatment and ongoing care of patients with diabetes indications. Commonly prescribed in hospital and retail pharmacy settings, it ensures measurable therapeutic benefit.
Crafted in state-of-the-art facilities, this tablet formulation ensures accuracy in dosing and ease of administration. It is typically available in secure blister or strip packs suitable for bulk export or institutional supply.
The product is manufactured in facilities adhering to WHO-GMP standards and complies with pharmacopoeial quality benchmarks (IP/USP). Ideal for regulated and semi-regulated markets seeking quality-assured medications.
Inclusive of all taxes
You Save: 0
Panchkula , India
Service Provider , Professional Services, Exporter, Wholesaler
GST- 06eogps3248l1zf
